Top Stories
Editors Picks
COMPANY ALERTS
Medicare’s 2.48% Boost: Who Really Wins?
Subscribe to Newsletter and Become a Member
Join our Global Markets Insider newsletter to stay ahead of the curve with expert insights on finance, stocks, exclusive reports, and global markets!
Latest News
Stand-By Golf Posts 70% Revenue Surge; TMGI Eyes OTCQB Uplisting (OTCID: TMGI)
THE VANDERBILT REPORT | Equity Research & Investor Intelligence | Bristol, TN Stand-By Golf Posts 70% Sequential
When Big Pharma Calls Without Being Asked, Pay Attention
— Special Deep-Dive Analysis · March 2026 — Artelo Biosciences (NASDAQ: ARTL) Three Platforms, One Molecule, A Pipeline
How NAPC Defense Turned a Strategic Asset Acquisition into a Multi-Billion Dollar Government Contracting Platform
Most defense contractors spend years building relationships and winning small contracts before they get access to the big
Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study
We’ve been tracking Artelo Biosciences (NASDAQ: ARTL) and today’s announcement represents the kind of strategic expansion that changes
Pay in Dollars, Colones or Plastic? The Currency Trap Tourists Are Walking Into in Costa
If you’ve lived in or visited Costa Rica for more than a week, you’ve probably heard someone mutter,
Why Oregon Just Became a Serious Gold Jurisdiction
Most gold discoveries today happen deeper and cost more to find. The industry spent two decades drilling further
What Tesla’s Compensation Vote Really Means
One trillion dollars buys more than wealth. It buys control. Tesla shareholders approved Elon Musk’s compensation package with
Atlas Athlete AI: Improve Your Child’s Athletic Performance and Prevent Injuries
Start your Assessment Today for $59.99! The Pressure Parents Feel If you’re the parent of a young athlete,
Worksport Breakout Quarter With Record Earnings
Worksport Ltd., reports record earnings and aggressive growth plans for 2026. With net sales soaring to $16.1 million
RenX Enterprises: Full-Year Results Beat Guidance, Q4 Compost Margins Signal Platform Inflection — And the
THE VANDERBILT REPORT Equity Research & Investor Intelligence BRISTOL, TN | April 5, 2026 NASDAQ: RENX | Investor
Stand-By Golf Posts 70% Revenue Surge; TMGI Eyes OTCQB Uplisting (OTCID: TMGI)
THE VANDERBILT REPORT | Equity Research & Investor Intelligence | Bristol, TN Stand-By Golf Posts 70% Sequential
How NAPC Defense Turned a Strategic Asset Acquisition into a Multi-Billion Dollar Government Contracting Platform
Most defense contractors spend years building relationships and winning small contracts before they get access to the big
Major Trends Reshaping Finance in 2025
Key Opportunities Inclusion & Financial Access: Many of these trends lower barriers (cost, geographic, technological) and can help
The $5,000 Gold Threshold That Changes Everything
Gold just crossed four thousand dollars per ounce. The question isn’t if it stays there. It’s whether five
Chase Bets Big On America’s Equity Goldmine
After five years away from home equity lines of credit, the banking giant quietly relaunched its HELOC product.
Vanderbilt Report: The $99.6 Million Bet on Milliseconds: Why VisionWave’s QuantumSpeed Acquisition Signals a Shift
VisionWave Holdings, Inc. (NASDAQ: VWAV) made a strategic $99.6 million acquisition of QuantumSpeed™, securing early-stage technology positioned to
Atlas Athlete AI: Improve Your Child’s Athletic Performance and Prevent Injuries
Start your Assessment Today for $59.99! The Pressure Parents Feel If you’re the parent of a young athlete,
Vanderbilt Report: NextTrip Bets Big On Group Travel Technology
Bristol, TN The group travel market reached $235.94 billion in 2024. NextTrip, Inc (Nasdaq: NTRP) bought the pipeline
Regional Banks Are Racing Against An Extinction Clock
Fifth Third just paid $10.9 billion for something money alone can’t buy. Scale. The deal with Comerica creates
Just In
Whats Happening
Jaguar Health, Inc. Plant-Based Pharmaceutical Innovation
Executive Summary Jaguar Health, Inc. (NASDAQ: JAGX) represents a unique investment opportunity in the specialty pharmaceutical sector, combining FDA-approved products with a robust pipeline targeting high-value orphan disease markets. With strong revenue growth momentum, breakthrough clinical
Whats Happening
Medicare’s 2.48% Boost: Who Really Wins?
We just witnessed one of the most dramatic policy reversals in health care financing history. On April
TECHNOLOGY
Why Invest in ZenaTech, Inc. (Nasdaq: ZENA)
Why Invest in ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ZENATECH, INC. (Nasdaq: ZENA) | (FSE: 49Q) | (BMV: ZENA) AI Drones • Drone as a Service • Enterprise SaaS • Quantum Computing A Multi-Segment
Recommended for you
MORE NEWS
Stand-By Golf Posts 70% Revenue Surge; TMGI Eyes OTCQB Uplisting (OTCID: TMGI)
THE VANDERBILT REPORT | Equity Research & Investor Intelligence | Bristol, TN Stand-By Golf Posts 70% Sequential Revenue Surge as Transglobal Management Group Targets OTCQB Uplisting and Primes GETGOLF
Jaguar Health, Inc. Plant-Based Pharmaceutical Innovation
Executive Summary Jaguar Health, Inc. (NASDAQ: JAGX) represents a unique investment opportunity in the specialty pharmaceutical sector, combining FDA-approved products with a robust pipeline targeting high-value orphan disease markets. With
